BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9583874)

  • 1. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
    VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
    Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
    Sirak J; Orosz CG; Wakely E; VanBuskirk AM
    Transplantation; 1997 May; 63(9):1300-7. PubMed ID: 9158025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns.
    Sirak JH; Orosz CG; Roopenian DC; Wakely E; VanBuskirk AM
    Transplantation; 1998 May; 65(10):1352-6. PubMed ID: 9625018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of graft acceptance: evidence that plasminogen activator controls donor-reactive delayed-type hypersensitivity responses in cardiac allograft acceptor mice.
    Bickerstaff AA; Xia D; Pelletier RP; Orosz CG
    J Immunol; 2000 May; 164(10):5132-9. PubMed ID: 10799871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
    Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
    Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The graft helps to define the character of the alloimmune response.
    Bickerstaff AA; Wang JJ; Pelletier RP; Orosz CG
    Transpl Immunol; 2002 May; 9(2-4):137-41. PubMed ID: 12180821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N
    Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a limited contribution of immune regulation to cardiac allograft acceptance.
    Bickerstaff A; Orosz C
    Hum Immunol; 2002 Oct; 63(10):935-47. PubMed ID: 12368046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft acceptance despite differential strain-specific induction of TGF-beta/IL-10-mediated immunoregulation.
    Bickerstaff AA; Wang JJ; Xia D; Orosz CG
    Am J Transplant; 2002 Oct; 2(9):819-27. PubMed ID: 12392287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice.
    Bickerstaff AA; VanBuskirk AM; Wakely E; Orosz CG
    Transplantation; 2000 Apr; 69(7):1517-20. PubMed ID: 10798784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
    Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
    Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local cellular immunology of experimental transplant vascular sclerosis.
    Orosz CG
    Clin Transplant; 1996 Feb; 10(1 Pt 2):100-3. PubMed ID: 8680044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
    Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
    Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM
    Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.